Company news
Seer, Inc. news in 2025
Seer, Inc.'s news releases, calls and decks from 2025, newest first.
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
December 1, 2025
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
November 7, 2025
Seer Reports Third Quarter 2025 Financial Results
November 6, 2025
Seer to Participate in Upcoming November Investor Conferences
October 29, 2025
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 16, 2025
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 16, 2025
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
October 10, 2025
Seer Appoints Isaac Ro to its Board of Directors
September 2, 2025
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 26, 2025
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
August 6, 2025
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
July 22, 2025
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
June 1, 2025
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
May 29, 2025
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
May 13, 2025
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
April 24, 2025
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
February 27, 2025
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
February 21, 2025
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
February 20, 2025
Calls in 2025
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 12 slides · Nov 6, 2025
- Q2 2025 Earnings Presentation
Earnings · 13 slides · Aug 6, 2025